Literature DB >> 28498587

Does neuroimaging have a role in predicting outcomes in psychosis?

Philip McGuire1, Paola Dazzan1.   

Abstract

Entities:  

Year:  2017        PMID: 28498587      PMCID: PMC5428193          DOI: 10.1002/wps.20426

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   79.683


× No keyword cloud information.
  10 in total

1.  Brain volume changes in the first year of illness and 5-year outcome of schizophrenia.

Authors:  W Cahn; N E M van Haren; H E Hulshoff Pol; H G Schnack; E Caspers; D A J Laponder; R S Kahn
Journal:  Br J Psychiatry       Date:  2006-10       Impact factor: 9.319

2.  Assessment of the increase in variability when combining volumetric data from different scanners.

Authors:  Santiago Reig; Javier Sánchez-González; Celso Arango; Josefina Castro; Ana González-Pinto; Felipe Ortuño; Benedicto Crespo-Facorro; Nuria Bargalló; Manuel Desco
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

3.  Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.

Authors:  Arsime Demjaha; Alice Egerton; Robin M Murray; Shitij Kapur; Oliver D Howes; James M Stone; Philip K McGuire
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

Review 4.  Biological determinants of difficult to treat patients with schizophrenia.

Authors:  T Sharma; R Kerwin
Journal:  Br J Psychiatry Suppl       Date:  1996-12

5.  Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes.

Authors:  J M Lappin; C Morgan; S Chalavi; K D Morgan; A A T S Reinders; P Fearon; M Heslin; J Zanelli; P B Jones; R M Murray; P Dazzan
Journal:  Psychol Med       Date:  2013-07-18       Impact factor: 7.723

6.  Power calculations for multicenter imaging studies controlled by the false discovery rate.

Authors:  John Suckling; Anna Barnes; Dominic Job; David Brenan; Katherine Lymer; Paola Dazzan; Tiago Reis Marques; Clare MacKay; Shane McKie; Steve R Williams; Steven C R Williams; Stephen Lawrie; Bill Deakin
Journal:  Hum Brain Mapp       Date:  2010-08       Impact factor: 5.038

7.  Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study.

Authors:  J Mourao-Miranda; A A T S Reinders; V Rocha-Rego; J Lappin; J Rondina; C Morgan; K D Morgan; P Fearon; P B Jones; G A Doody; R M Murray; S Kapur; P Dazzan
Journal:  Psychol Med       Date:  2011-11-07       Impact factor: 7.723

Review 8.  Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.

Authors:  Paola Dazzan; Celso Arango; Wolfgang Fleischacker; Silvana Galderisi; Birte Glenthøj; Stephan Leucht; Andreas Meyer-Lindenberg; Rene Kahn; Dan Rujescu; Iris Sommer; Inge Winter; Philip McGuire
Journal:  Schizophr Bull       Date:  2015-03-23       Impact factor: 7.348

9.  White matter integrity as a predictor of response to treatment in first episode psychosis.

Authors:  Tiago Reis Marques; Heather Taylor; Chris Chaddock; Flavio Dell'acqua; Rowena Handley; A A T Simone Reinders; Valeria Mondelli; Stefania Bonaccorso; Marta Diforti; Andrew Simmons; Anthony S David; Robin M Murray; Carmine M Pariante; Shitij Kapur; Paola Dazzan
Journal:  Brain       Date:  2013-11-19       Impact factor: 15.255

10.  Cortical folding defects as markers of poor treatment response in first-episode psychosis.

Authors:  Lena Palaniyappan; Tiago Reis Marques; Heather Taylor; Rowena Handley; Valeria Mondelli; Stefania Bonaccorso; Annalisa Giordano; Grant McQueen; Marta DiForti; Andrew Simmons; Anthony S David; Carmine M Pariante; Robin M Murray; Paola Dazzan
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 25.911

  10 in total
  6 in total

Review 1.  Neuroimaging in Schizophrenia.

Authors:  Matcheri S Keshavan; Guusje Collin; Synthia Guimond; Sinead Kelly; Konasale M Prasad; Paulo Lizano
Journal:  Neuroimaging Clin N Am       Date:  2019-11-11       Impact factor: 2.264

2.  Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Authors:  Daniel J Hauke; André Schmidt; Erich Studerus; Christina Andreou; Anita Riecher-Rössler; Joaquim Radua; Joseph Kambeitz; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Theresa Lichtenstein; Rachele Sanfelici; Nora Penzel; Shalaila S Haas; Linda A Antonucci; Paris Alexandros Lalousis; Katharine Chisholm; Frauke Schultze-Lutter; Stephan Ruhrmann; Jarmo Hietala; Paolo Brambilla; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Pantelis; Marlene Rosen; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Stefan Borgwardt
Journal:  Transl Psychiatry       Date:  2021-05-24       Impact factor: 6.222

Review 3.  Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders.

Authors:  Thomas A Pollak; Jonathan P Rogers; Robert G Nagele; Mark Peakman; James M Stone; Anthony S David; Philip McGuire
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

4.  Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies.

Authors:  S E Smart; A P Kępińska; R M Murray; J H MacCabe
Journal:  Psychol Med       Date:  2019-08-29       Impact factor: 7.723

Review 5.  Markers of Schizophrenia-A Critical Narrative Update.

Authors:  Beata Galińska-Skok; Napoleon Waszkiewicz
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

6.  Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study.

Authors:  Paola Dazzan; Andrew J Lawrence; Antje A T S Reinders; Alice Egerton; Neeltje E M van Haren; Kate Merritt; Gareth J Barker; Rocio Perez-Iglesias; Kyra-Verena Sendt; Arsime Demjaha; Kie W Nam; Iris E Sommer; Christos Pantelis; W Wolfgang Fleischhacker; Inge Winter van Rossum; Silvana Galderisi; Armida Mucci; Richard Drake; Shon Lewis; Mark Weiser; Covadonga M Martinez Diaz-Caneja; Joost Janssen; Marina Diaz-Marsa; Roberto Rodríguez-Jimenez; Celso Arango; Lone Baandrup; Brian Broberg; Egill Rostrup; Bjørn H Ebdrup; Birte Glenthøj; Rene S Kahn; Philip McGuire
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 7.348

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.